Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
DXCM DexCom
- 87.090
- +0.770+0.89%
Close Jan 22 16:00 ET
- 86.601
- -0.489-0.56%
Pre 08:00 ET
34.02BMarket Cap52.78P/E (TTM)
88.205High85.720Low3.18MVolume85.850Open86.320Pre Close276.94MTurnover0.82%Turnover Ratio66.99P/E (Static)390.60MShares142.00052wk High17.19P/B33.76BFloat Cap62.34052wk Low--Dividend TTM387.69MShs Float164.863Historical High--Div YieldTTM2.88%Amplitude0.340Historical Low87.214Avg Price1Lot Size
About DexCom Company
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Company Profile
SymbolDXCM
Company NameDexCom
Listing DateApr 14, 2005
Issue Price12.00
Founded1999
CEOMr. Terrance H. Gregg
MarketNASDAQ
Employees9600
Fiscal Year Ends12-31
Address6340 Sequence Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-200-0200
Websitehttp://www.dexcom.com
Company Executives
- Name
- Position
- Salary
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 15.71M
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 4.34M
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 4.25M
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 6.53M
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 4.94M
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Rimma Driscoll
- Independent Director
- 404.72K
- Bridgette P. Heller
- Independent Director
- 346.49K
- Kyle Malady
- Independent Director
- 343.40K
- Nicholas Augustinos
- Independent Director
- 362.21K
- Steven R. Altman
- Independent Director
- 343.40K
- Richard A. Collins
- Independent Director
- 345.90K
- Mark G. Foletta
- Lead Independent Director
- 393.51K
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 346.49K
- Karen M. Dahut
- Independent Director
- 345.90K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
As Tesla's earnings near, will its stock soar?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft
BullnBearTrading
Jan 3 16:30
🚗 Tesla Q4 Dip: Time to Buy , or Is the Risk Too High? 📉